FDA-mandated post-market studies are here. Phase IV clinical studies are likely to be complex in design and large in scale (possibly 500,000 patients per arm), with exacting endpoints, and obligatory. The FDA appears to be abandoning a long-standing policy of negotiating post-market commitments with sponsors - and will now set mandatory objectives and timelines.

Date : 5th May 2015 to 5th May 2015

Place : United States, New hyde park

Website :https://www.complianceglobal.us/product/700063

Contact Person:Compliance Global Inc

Description:

FDA-mandated post-market studies are here. Phase IV clinical studies are likely to be complex in design and large in scale (possibly 500,000 patients per arm), with exacting endpoints, and obligatory. The FDA appears to be abandoning a long-standing policy of negotiating post-market commitments with sponsors - and will now set mandatory objectives and timelines.

FDA-mandated post-market studies are here. Phase IV clinical studies are likely to be complex in design and large in scale (possibly 500,000 patients per arm), with exacting endpoints, and obligatory. The FDA appears to be abandoning a long-standing policy of negotiating post-market commitments with sponsors - and will now set mandatory objectives and timelines. will be held in New hyde park,United States on date 2015-05-05

---

Deadline for abstracts/proposals : 5th May 2015

Keynote Speakers :

Check the event website for more details.